Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new release label Revision: v3.6.6 was added and the previous Revision: v3.6.5 was removed in the record history, reflecting an update to the page's revision listing rather than substantive study content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe record history now reflects a new revision entry for version v3.6.5, replacing the previous v3.6.4 entry in the history list.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.6.4 was added in the Record History, replacing the previous v3.6.3, indicating an update to the study record version.SummaryDifference0.1%

- Check75 days agoChange DetectedThe study's record history now includes a new revision entry, v3.6.3, indicating an updated version of the record. The history diff also shows the previous revision v3.6.2 as removed from the displayed entries.SummaryDifference0.1%

- Check82 days agoChange DetectedAn updated revision entry, v3.6.2, was added to the study record history. It replaces the previous v3.6.0 entry, signaling a newer release of the record.SummaryDifference0.1%

- Check96 days agoChange DetectedThe history now shows that recruitment has ended for the study ('No longer looking for participants'). A new release note 'Revision: v3.6.0' was added and the previous release 'Revision: v3.5.5' was removed.SummaryDifference0.4%

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.